Lord’s Mark Industries Limited has achieved a new milestone in healthcare manufacturing, securing, according to the company, US FDA registration for more than 200 surgical, medical-care and hygiene products. The company plans to commence exports to the United States in December 2026, marking a major step in its international expansion strategy. With its Silvassa manufacturing capacity expansion completed ahead of schedule, Lord’s Mark Industries is also preparing to explore opportunities across South America, subject to applicable country-specific regulatory requirements.
The development comes as the company completes its manufacturing capacity expansion at Silvassa ahead of schedule, strengthening its production readiness for international markets. With a diversified portfolio spanning orthopaedic supports, rehabilitation aids, mobility solutions, hygiene products and medical-care essentials, Lord’s Mark Industries aims to build a scalable export business from India.
